Bezafibrate 400 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bezafibrate 400 mg, covering 2025-08-27 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy [Phase 3]